Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of the Thrombospondin-1–Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Cancer Clinicians often assume that children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback